OK Biotech Co., Ltd. / Fundamentals

    Income statement

    Net revenue
    €48.10M
    Cost of goods sold
    €38.63M
    Gross profit
    €9.47M
    SG&A expenses
    €6.24M
    R&D expenses
    €1.74M
    EBITDA
    €1.90M
    D&A
    €2.28M
    EBIT
    €1.49M
    Interest expenses
    €222.44K
    EBT
    -€580.81K
    Tax expenses
    €114.72K
    Net income
    -€1.14M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €1.07M
    Changes in working capital
    -€4.54M
    Operating cash flow
    -€1.25M
    Capex
    €14.68M
    Other investing cash flow
    €168.04K
    Net investing cash flow
    -€14.05M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    €12.29M
    Other financing cash flow
    -€2.14M
    Net financing cash flow
    €10.15M
    Foreign exchange effects
    -€285.59K
    Net change in cash
    -€5.44M
    Cash at end of period
    €4.65M
    Free cash flow
    €13.42M

    Balance sheet

    Cash and cash equivalents
    €4.65M
    Cash and short-term investments
    €4.98M
    Total receivables
    €13.27M
    Inventory
    €13.89M
    Other current assets
    €2.59M
    Total current assets
    €34.73M
    Property, plant & equipment
    €51.69M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €1.41M
    Total non-current assets
    €67.97M
    Total assets
    €102.70M
    Accounts payable
    €4.36M
    Short-term debt
    €11.81M
    Other current liabilities
    €3.01M
    Total current liabilities
    €19.19M
    Long-term debt
    €14.23M
    Deferred tax liabilities
    €773.07K
    Other non-current liabilities
    €93.05K
    Total non-current liabilities
    €15.09M
    Total liabilities
    €34.28M
    Common stock
    €41.14M
    Retained earnings
    -€1.10M
    Other equity
    €0.00
    Total equity
    €68.42M
    Total liabilities and shareholders' equity
    €102.70M

    Company information

    Market capitalization
    €70.25M
    Employees
    0
    Enterprise Value
    €3.14B

    Company ratios

    Gross margin
    19.7% Much worse than peer group: 42.9%
    EBITDA margin
    3.9% Worse than peer group: 14.8%
    EBIT margin
    3.1% Even with peer group: 5.9%
    EBT margin
    -1.2% Worse than peer group: 8.4%
    Net margin
    -2.4% Worse than peer group: 6.5%
    ROE
    -1.7% Worse than peer group: 5.4%
    ROA
    -1.1% Worse than peer group: 3.9%
    Asset turnover
    46.8% Even with peer group: 47.5%
    FCF margin
    -33.1% Much worse than peer group: 0.8%
    FCF yield
    -22.7%
    Efficiency ratio
    96.1%
    Net sales per employee
    €0.00
    Net income per employee
    €0.00

    Notifications